rxstatClasses › Direct Acting Antivirals

Direct Acting Antivirals: shortage status in Canada

15 of the 33 direct acting antivirals rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.
Partial shortageAdefovir Dipivoxil1 of 2 reported products affectedPartial shortageAtazanavir3 of 8 reported products affectedPartial shortageDarunavir2 of 9 reported products affected · est. return Jul 24, 2026Partial shortageEfavirenz1 of 6 reported products affectedPartial shortageEfavirenz Tenofovir Disoproxil Emtricitabine3 of 7 reported products affected · est. return Dec 31, 2026Partial shortageEntecavir2 of 5 reported products affected · est. return Aug 7, 2026Partial shortageFamciclovir3 of 17 reported products affectedPartial shortageLamivudine1 of 6 reported products affected · est. return Jul 3, 2026Partial shortageLamivudine Abacavir1 of 7 reported products affectedPartial shortageNevirapine1 of 6 reported products affectedPartial shortageOseltamivir1 of 6 reported products affectedPartial shortageTenofovir Disoproxil2 of 6 reported products affectedPartial shortageTenofovir Disoproxil Emtricitabine2 of 5 reported products affectedPartial shortageValacyclovir4 of 21 reported products affected · est. return Sep 29, 2026Partial shortageValganciclovir2 of 6 reported products affected · est. return Feb 28, 2027DiscontinuedAsunaprevir0 of 1 reported products affectedDiscontinuedAtazanavir Cobicistat0 of 1 reported products affectedDiscontinuedDelavirdine0 of 1 reported products affectedDiscontinuedDidanosine0 of 4 reported products affectedDiscontinuedEmtricitabine0 of 1 reported products affectedDiscontinuedEnfuvirtide0 of 1 reported products affectedDiscontinuedFosamprenavir0 of 2 reported products affectedNo current shortageInosine PranobexNo current shortageLetermovirDiscontinuedNelfinavir0 of 2 reported products affectedDiscontinuedOmbitasvir Paritaprevir Ritonavir0 of 1 reported products affectedDiscontinuedRitonavir Ombitasvir Dasabuvir Paritaprevir0 of 1 reported products affectedDiscontinuedSaquinavir0 of 2 reported products affectedDiscontinuedStavudine0 of 4 reported products affectedDiscontinuedTelbivudine0 of 1 reported products affectedDiscontinuedTipranavir0 of 1 reported products affectedDiscontinuedZidovudine Abacavir Lamivudine0 of 2 reported products affectedNo current shortageZidovudine Lamivudine

Guides: what to do when your medication is in shortage · how to read these statuses

Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.